Gilead Sciences, Inc.
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 15, 2020.
Bristol Myers Squibb is prepared for an additional windfall of cash after a judge boosted the damages the company is due from Gilead Sciences over a patent infringement regarding the technology related to a novel cancer therapy.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 13, 2020.
The study of the 53 patients in the U.S., Europe and Canada who required respiratory support showed that about two-thirds benefited from the drug.
It was a very busy week for clinical trial news. Here’s a look.
Although the data hasn’t been released yet, analysts are making predictions based on what little they do know.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
Gilead Sciences and Second Genome forged a four-year strategic collaboration that will boost chances to discover and develop new targets and drug candidates for the treatment of inflammatory bowel disease through microbiome research.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
JOBS
IN THE PRESS